Benralizumab for treating severe eosinophilic asthma
Technology appraisal guidance
Reference number: TA565
Published:
Last updated:
The company has updated the patient access scheme for benralizumab. The new scheme will be considered in a closed session at the committee meeting on 15 November 2018. We will communicate the next steps once the outcome of that meeting is known.